跳至主要内容
临床试验/JPRN-UMIN000031797
JPRN-UMIN000031797已完成未知

Transcatheter arterial micro-embolization (TAME) using imipenem/cilastatin sodium for chronic musculoskeletal pain chronic musculoskeletal pain resistant to conservative treatment - Clinical efficacy of TAME for chronic musculoskeletal pain

Wakayama medical university0 个研究点目标入组 50 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Surgical candidate 2)Patients with major depression 3)Patients with uncontrollable diabetic mellitus 4)Patients without possibility of going to hospital and follow up for 6 months. 5)Patient who was decided not to be appropriate for this trial by physician 6)Patients with a history of hypersensitivity or shock to antibiotics of imipenem . cilastatin, carbapenem, penicillin or cephem 7)Patients who are receiving sodium valproate 8)Patients with a history of severe thrombotic symptoms such as myocardial infarction and cerebral infarction 9)Patients diagnosed as anti-phospholipid antibody syndrome 10)Patients performing antiplatelet drugs or anticoagulation therapy 11)Patients diagnosed as collagen diseases such as rheumatoid arthritis and polymyalgia rheumatic 12)Pregnant patient

研究者

相似试验